- Tytuł:
-
Differential liver function at cessation of atezolizumabbevacizumab versus lenvatinib in HCC: a multicenter,
propensity -score matched comparative study. - Autorzy:
- Temat:
-
PROPENSITY score matching
LIVER
PROGRESSION-free survival - Źródło:
-
Frontiers in Oncology ; 2024, p1-11, 11p
Czasopismo naukowe